Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Lindén

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Journal of Lipid Research|November 21, 2001
PPARalpha deficiency increases secretion and serum levels of apolipoprotein B-containing lipoproteinsD Lindén, M Alsterholm, H Wennbo, et al.
American Journal of Physiology. Endocrinology and Metabolism|September 12, 2001
Effects of fatty acids and growth hormone on liver fatty acid binding protein and PPARalpha in rat liverL Carlsson, D Lindén, M Jalouli, et al.
American Journal of Physiology. Endocrinology and Metabolism|November 30, 2000
Direct effects of growth hormone on production and secretion of apolipoprotein B from rat hepatocytesD Lindén, A Sjöberg, L Asp, et al.
American Journal of Physiology. Endocrinology and Metabolism|November 10, 2001
Long-term growth hormone excess induces marked alterations in lipoprotein metabolism in miceF Frick, M Bohlooly-Y, D Lindén, et al.
CPT: Pharmacometrics & Systems Pharmacology|May 31, 2017
Translational Modeling to Guide Study Design and Dose Choice in Obesity Exemplified by AZD1979, a Melanin-concentrating Hormone Receptor 1 AntagonistP Gennemark, M Trägårdh, D Lindén, et al.
Journal of Medical Screening|January 1, 1996
Screening for cutaneous malignant melanoma: a feasibility studyS Törnberg, E Månsson-Brahme, D Lindén, et al.
British Journal of Pharmacology|December 24, 2010
Low dose of the liver X receptor agonist, AZ876, reduces atherosclerosis in APOE*3Leiden mice without affecting liver or plasma triglyceride levelsJwa van der Hoorn, D Lindén, U Lindahl, et al.
Nature Communications|August 30, 2022
Early macrophage response to obesity encompasses Interferon Regulatory Factor 5 regulated mitochondrial architecture remodellingL Orliaguet, T Ejlalmanesh, A Humbert, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Journal of Lipid Research|November 21, 2001
PPARalpha deficiency increases secretion and serum levels of apolipoprotein B-containing lipoproteinsD Lindén, M Alsterholm, H Wennbo, et al.
American Journal of Physiology. Endocrinology and Metabolism|September 12, 2001
Effects of fatty acids and growth hormone on liver fatty acid binding protein and PPARalpha in rat liverL Carlsson, D Lindén, M Jalouli, et al.
American Journal of Physiology. Endocrinology and Metabolism|November 30, 2000
Direct effects of growth hormone on production and secretion of apolipoprotein B from rat hepatocytesD Lindén, A Sjöberg, L Asp, et al.
American Journal of Physiology. Endocrinology and Metabolism|November 10, 2001
Long-term growth hormone excess induces marked alterations in lipoprotein metabolism in miceF Frick, M Bohlooly-Y, D Lindén, et al.
CPT: Pharmacometrics & Systems Pharmacology|May 31, 2017
Translational Modeling to Guide Study Design and Dose Choice in Obesity Exemplified by AZD1979, a Melanin-concentrating Hormone Receptor 1 AntagonistP Gennemark, M Trägårdh, D Lindén, et al.
Journal of Medical Screening|January 1, 1996
Screening for cutaneous malignant melanoma: a feasibility studyS Törnberg, E Månsson-Brahme, D Lindén, et al.
British Journal of Pharmacology|December 24, 2010
Low dose of the liver X receptor agonist, AZ876, reduces atherosclerosis in APOE*3Leiden mice without affecting liver or plasma triglyceride levelsJwa van der Hoorn, D Lindén, U Lindahl, et al.
Nature Communications|August 30, 2022
Early macrophage response to obesity encompasses Interferon Regulatory Factor 5 regulated mitochondrial architecture remodellingL Orliaguet, T Ejlalmanesh, A Humbert, et al.
Pageof 1